up to 64 cells, Sox-9 was identified in all cells, along with c-Myc, nucleostemin and the proteolytic enzymes. RT-PCR confirmed expression of nucleostemin, c-myc and Sox-9. Conclusions: Early expression of c-myc may indicate temporary genomic instability, i.e. a gene expression pattern in flux. Because nucleostemin is found only in stem cells or cancer, the presence in clonal chondrocytes is surprising and suggests that chondrocytes undergo a de-differentiation to a progenitor-like intermediate. The re-activation of Sox-9 in late clones suggests reversion to an earlier chondrocytic differentiation stage. Overall, the findings suggest that OA chondrocytes, because they still retain some chondrocytic characteristics, display a complicated and mixed phenotype, with degradative chondrocytes arising from a progenitor-cell like intermediate stage, followed by re-differentiation. At the same time, the observations do not support the concept of continued differentiation to hypertrophic chondrocytes. After enzymatic digestion chondrocytes were plated at high-density monolayers and either transfected with OP-1 antisense oligos in the presence of lipofectin or treated with rhOP-1 for 48 hours followed by RNA isolation. Gene expression profile was analyzed by HG-U133A gene chips from Affimetrix. RNA within each treatment group was pooled from all donors. Statistical analysis consisted of 1) analysis of differentially expressed genes under single experimental condition in comparison to control (up-or down-regulated in the presence of OP-1 antisense or rhOP-1); 2) analysis of differentially regulated genes by both treatments (OP-1 antisense and rhOP-1); and 3) gene ontology. Selected gene array data were verified experimentally in vitro or by real-time PCR.
Purpose: Osteogenic Protein-1 (OP-1) is a potent growth factor for cartilage repair due to its pro-anabolic and anti-catabolic activities. Our goal was to evaluate the role of OP-1 in human cartilage homeostasis by gene array under conditions of lack (inhibition of endogenous OP-1 gene by antisense oligos) or excess of OP-1 (stimulation with recombinant OP-1 ). This report is limited to the effect on anabolic genes (growth factors, regulators of their signaling and matrix proteins) and catabolic genes (inflammatory cytokines, their receptors, proteinases, and transcription factors). Methods: Human normal adult articular cartilage was obtained from the ankle joints of 12 tissue donors, age 55-70 y/o, within 24 hours of death. After enzymatic digestion chondrocytes were plated at high-density monolayers and either transfected with OP-1 antisense oligos in the presence of lipofectin or treated with rhOP-1 for 48 hours followed by RNA isolation. Gene expression profile was analyzed by HG-U133A gene chips from Affimetrix. RNA within each treatment group was pooled from all donors. Statistical analysis consisted of 1) analysis of differentially expressed genes under single experimental condition in comparison to control (up-or down-regulated in the presence of OP-1 antisense or rhOP-1); 2) analysis of differentially regulated genes by both treatments (OP-1 antisense and rhOP-1); and 3) gene ontology. Selected gene array data were verified experimentally in vitro or by real-time PCR.
Results:
The results showed that the inhibition of endogenous OP-1 led to down-regulation of a number of anabolic genes among which were the members of the IGF-1 pathway: IGF-1 receptor (1.73-fold decrease), IGFBP-5 (1.9 fold) and IGFBP-7 (1.58-fold, P<0.01). In vitro validation experiments confirmed and extended these findings: in chondrocytes treated with OP-1 antisense expression of IGF-1 and its receptor was down-regulated, while stimulation with rhOP-1 up-regulated their expression. This in turn restored the response to IGF-1 diminished with aging of human cartilage. Antisense inhibition of OP-1 reduced gene expression of the TGF-β/BMP receptors and downstream signaling/regulatory molecules. RhOP-1 inhibited BMP-2 (2.67-fold), , and activin (2.32-fold) expression. The following matrix proteins were regulated by OP-1: rhOP-1 induced collagen type IX, COMP, and cadherin genes; while OP-1 antisense reduced collagen type VI, versican, syndecan, bone sialoprotein, and other genes. Among catabolic genes the most affected by OP-1 were leukemia inhibitory factor (LIF), IL-6, IL-8, IL-11, IL-1 and IL-6 receptors, NF-κB and AP-2. Inhibition of OP-1 caused a 2-fold increase in their expression (p<0.001), while treatment with rhOP-1 dramatically inhibited these genes: LIF by 15.86-fold; IL-6 by 2-fold; IL-8 by 4.0-fold; and IL-11 by 8.69-fold (p<0.001). These changes were confirmed by real-time PCR. In addition, OP-1 was not only able to reduce gene expression of autocrine cytokines, but counteracted their inhibitory effect on proteoglycan synthesis. OP-1 also inhibited MMP-14 and TIMP-3, some caspases, ADAMs and ADAM-TSs.
Conclusions:
The initial analysis of gene array data strongly suggests a critical role of OP-1 in cartilage homeostasis. OP-1 regulates numerous metabolic pathways that are not only limited to its anabolic function, but also to its anti-catabolic activity. Understanding of OP-1 function in cartilage will provide strong justification for the application of OP-1 protein as therapeutic treatment for cartilage regeneration and repair.
P131 THE EFFECTS OF A SINGLE FAST IMPACT LOAD COMPARED WITH SLOW SEVERE LOADING ON ARTICULAR CARTILAGE IN VITRO
J.E. Jeffrey, J.P. Brodie, R.M. Aspden University of Aberdeen, Aberdeen, United Kingdom Purpose: Traumatic injury to a joint is known to increase the risk of developing secondary osteoarthritis (OA). Various in-vitro models of injurious loading have been employed to simulate the effects of joint injury on articular cartilage. The aim of this study was to compare two of the most common types of pathological loading models; a single, fast impact load and a slow, severe load. Methods: Full depth, circular explants (5 mm diameter) of articular cartilage were removed from the subchondral bone of two human femoral heads using a cork borer and scalpel and cultured for 24 h to equilibrate. Explants (n = 24 from each femoral head), were matched for initial thickness into 3 groups. One group was subjected to a single, fast impact load using a 500 g mass dropped from a height of 25 mm in a drop tower. The mean maximum strain was found and the second group subjected to loading to the same strain in an Instron materials testing machine at the fastest available cross-head speed of 40 mm s -1 . The third group served as a control. The modulus was determined from the maximum gradient of the stress/strain curve for each load. All explants were then cultured for either 24 h or 72 h. Chondrocyte viability was determined in transverse sections (∼500 μm) using the fluorescein diacetate/propidium iodide method. Frozen cartilage sections (8 μm) were used to evaluate apoptotic cell death (TUNEL), matrix damage (haematoxylin and eosin stain), and glycosaminoglycan (GAG) distribution (toluidine blue stain). Results: The peak stress of the fast, impact load was 21.7 ± 0.4 MPa and was reached after 1.5 ± 0.1 ms giving a peak modulus for cartilage of 87.8 ± 13.0 MPa. In comparison, for slow, severe loading, the peak stress was 0.8 ± 0.2 MPa, with a duration of 42.4 ± 1.6 ms and a peak modulus of 4.5 ± 1.4 MPa. Macroscopically, the explants subjected to slow, severe loading were considerably more damaged than those that were fast impacted; becoming flattened and elliptical in shape with extensive fissuring. The number of dead cells was also greater with this type of loading and, after 72 h, only a few viable cells were visible in the superficial layer. Slow load resulted in about 70% of chondrocytes becoming apoptotic by 24 h, and this was unchanged after 72 h. In contrast, impact loaded explants only had about 10% apoptotic cells (similar to unloaded controls) at 24 h but this increased to around 50% after 72 h. Histology confirmed that slow, severe loading caused considerably more damage than fast, impact load with the presence of fissuring and uneven GAG distribution particularly in the deeper zones of the tissue. Conclusions: Although producing the same strain in the explant, fast, impact loading was less damaging to cartilage than severe loading that took almost 30 times longer to reach peak stress. Induction of apoptosis was more rapid with severe loading although similar levels were reached in both methods after 3 days in culture. The higher modulus, a measure of resistance to deformation, in the fast, impact loading may explain the increased ability of the cartilage to protect itself from damaging stress levels. The peak stresses reached in the fast, impact loading were more than 20 times that of the slow, severe load suggesting that stress alone is not a good indicator of damage. (HO-1) . In the present work, we have investigated the possible anabolic and anticatabolic effects of HO-1 induction. Methods: Cartilage specimens were obtained from 43 patients with diagnosis of advanced OA undergoing total knee joint replacement. Chondrocytes were used in primary culture. Explants and cells were treated for 6 days or 24 h, respectively, with 100 U/ml IL-1β in the absence or presence of 10 μM of the HO-1 inducer cobalt protoporphyrin IX (CoPP). Glycosaminoglycan (GAG) degradation or synthesis was assayed by the release or incorporation of 35 SO 4 2-. Gene expression was assessed by real time PCR, protein levels by ELISA and western blot, MMPs activity by fluorometry and oxidative stress by LSC. Results: CoPP strongly induced HO-1 either in the presence or absence of IL-1β, whereas IL-1β stimulation of OA chondrocytes led to reductions in HO-1 protein and mRNA. HO-1 induction inhibited oxidative stress in IL-1β-stimulated chondrocytes. In cartilage explants, HO-1 induction protected against the degradation of aggrecan, as measured by GAG release. IGF1and IGFBP3 production was up-regulated in OA chondrocytes by HO-1. This was accompanied by a significant increase in GAG synthesis in chondrocytes. In addition, HO-1 significantly decreased MMPs activity in supernatants from OA chondrocytes stimulated with IL-1β. Transfection of chondrocytes with a human HO-1 siRNA prevented the effects of CoPP. Conclusions: HO-1 induction controls oxidative stress-related events linked to the developmentt of OA and exerts a number of effects relevant for cartilage homeostasis. Therefore, HO-1 prevents cartilage degradation through the enhancement of anabolic factors production and proteoglycan synthesis while suppressing catabolic mediators in OA chondrocytes. Purpose: In osteoarthritis (OA) progressive erosion of cartilage is associated with a phenotypic change to OA chondrocytes that express proteases and other abnormal genes. This aberrant expression pattern is thought to be linked to a loss of DNA methylation in the respective promoters. We hypothesize that OA chondrocytes produce a factor that diffuses to adjacent normal chondrocytes where loss of DNA methylation as well as gene transcription is induced. To test the hypothesis, we selected MMP-13 and IL-1β and examined the effects of the demethylation agent 5-aza-deoxycytidine (5-aza-dC) or of co-culture with superficial-zone OA chondrocytes on normal chondrocytes. Methods: Cells were isolated from human articular cartilage obtained, with ethical permission and patients' consent, from the femoral heads after arthroplasty for OA or hemi-arthroplasty following a fracture of the femoral neck (#NOF). The normal chondrocytes from each #NOF patient were divided into four groups: non-culture; control culture; culture with 5-aza-dC; coculture with OA superficial zone chondrocytes. The cells were cultured without passaging until reaching confluence (4-5 weeks) after which RNA and DNA were extracted simultaneously. Realtime qPCR was used to quantify mRNA expression as well as the % of methylation at one specific CpG site in each promoter region (-103 for MMP-13, -289 for IL-1β), which had been shown to be important in the epigenetic regulation. Results: In non-cultured chondrocytes from the #NOF patients, absence of MMP-13 and IL-1β expression correlated with 80-100% methylation of the CpG sites, as expected. After culture per se, expression levels had increased slightly and a slight, but non-significant loss of DNA methylation was recorded. As expected, culture with 5-aza-dC reduced the % methylation to 20-50%. At the same time the expression of MMP-13 or IL-1β increased 5-9 fold. The same type of effect was observed after co-culture with superficial zone OA chondrocytes: A significant reduction in methylation to 50-70% correlated with a 5-7 fold increase in gene expression. However, there were variations in this pattern in different patients: In two cases, loss of methylation by 5-aza-dC did not induce gene expression and in one case, induction of gene expression was not associated with loss of methylation. Conclusions: Previously, only an association between demethylation and abnormal MMP-13 expression had been shown, here we provide the first direct evidence that gene expression of MMP-13 and IL-1β in OA is, at least in part, regulated by DNA methylation, since demethylation by 5-aza-dC resulted in induction of MMP-13 and IL-1β in normal articular chondrocytes. The effect was replicated by a factor released from superficial zone OA chondrocytes, which in vivo might be involved in the progression of the disease. DNA demethylation is necessary, but not sufficient for inducing gene expression, the presence of the right transcription factors is also required. Such factors may be present in some #NOF patients, but not in others, which may explain those instances where loss of methylation was not linked to induction of transcription. On the other hand, it is feasible that gene expression may be induced in some cases without changes in methylation status. Nevertheless, we have shown that loss DNA methy[[Unsupported Character -Codename &shy;]]lation plays an important role in the induction of abnormal gene expression by OA chondrocytes.
P132 HEME OXYGENASE-1 MODULATES INSULIN GROWTH FACTOR-1 AND METALLOPROTEINASES IN OSTEOARTHRITIC CHONDROCYTES

P133 LOSS OF DNA METHYLATION IS CAUSED BY A FACTOR DERIVED FROM OA CHONDROCYTES WHICH INDUCES MMP-13 AND IL-1β EXPRESSION IN NORMAL HUMAN ARTICULAR CHONDROCYTES
